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native for the passive support offered by IABP. We recently
initiated a head-to-head randomized comparison of IABP and
Impella support in hemodynamically compromised patients with
large anterior STEMI.
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Letters to the Editor
Role of Percutaneous Coronary




In their interesting study, Sianos et al. (1) investigated the impact
of thrombus burden on the clinical outcome and angiographic
infarct-related artery (IRA) stent thrombosis in patients routinely
treated with drug-eluting stent implantation for ST-segment
elevation myocardial infarction (STEMI). Intracoronary thrombus
burden was angiographically scored before stenting using the
classification in 5 grades previously described by Gibson et al. (2).
Because a majority of patients suffering an acute STEMI present
with an occluded IRA that precludes any thrombus classification,
the investigators proposed to reclassify thrombus burden after flow
restoration was obtained by a minimal intervention based on the
use of a guidewire crossing or small (diameter 1.5 mm) deflated
balloon passage or dilation. It would have been interesting to know
the level of flow achievement based on Thrombosis In Myocardial
Infarction (TIMI) flow grade obtained by minimal intervention
among patients with totally occluded IRA in the study of Sianos
et al. (1), because similar minimal intervention without immediate
stenting has been previously proposed for direct reperfusion of
patients with acute STEMI (3). In their study (1), the investigators
found that a large thrombus burden is an independent predictor of
long-term mortality. Analysis of Table 1 shows (1), however, that
when compared with patients with a small thrombus burden,
patients with a large thrombus burden had higher rates of use of
intra-aortic balloon pump and inotropes, and they more frequently
had diabetes mellitus, stent thrombosis at presentation, and pace-
maker implantation. Also, although it is widely recognized as a
major predictor of clinical outcome in patients with STEMI, left
ventricular ejection fraction has not been reported in the study by
Sianos et al. (1). Entering all of these additional variables into the
multivariate analysis model might have changed the results pre-
sented in their Table 3 (1) regarding the independent role of
thrombus burden for 2-year mortality. The results of the study by
Sianos et al. (1) regarding procedural outcome (Table 4 in their
article) support the hypothesis and the data of a previously
published work (3), in which it was suggested that immediate
stenting should probably be avoided in many patients in the
acute phase of STEMI once flow has been restored using
minimalist intervention. Therefore, there is a need for a
randomized trial in which the classical approach of direct
percutaneous intervention with immediate stenting would be
compared with stent implantation strategy based on thrombus
burden analysis after flow restoration by immediate minimalist
intervention.
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Reply
We appreciate the interest of Dr. Isaaz for our work ( 1). In regard
to our initial analysis, we did not calculate the flow after the
minimal intervention in patients who presented with occluded
vessels, but further to this request this parameter was randomly
(every second) estimated in one-half (225) of these patients;
Thrombolysis In Myocardial Infarction (TIMI) flow grade 1 was
restored in 46.6%, TIMI flow grade 2 in 38.8%, and TIMI flow
grade 3 in 14.6%.
The imbalances in the baseline characteristics among groups
are related to the retrospective nonrandomized nature of our
study. Appropriate multivariable statistical analysis was per-
formed to account for these imbalances. For the same reason,
established parameters related to clinical outcomes were missing
as addressed in the extensive limitations paragraph. The influ-
ence of the baseline characteristics imbalances and missing
parameters on the results of the study remains speculative. For
example, during the review process, we were asked to perform
the analysis excluding the patients presenting with stent throm-
bosis. By doing so, no difference was observed in the resultant
independent predictors including large thrombus burden.
By no means could our results support the hypothesis that
immediate stenting can probably be avoided in many patients at
the acute phase of ST-segment elevation myocardial infarction
(STEMI) once flow has been restored using minimal intervention,
since all of our patients were stented during the index procedure.
Such an approach partly questions the well-established superiority
of bare-metal stents compared with balloon angioplasty (2– 4), and
beyond the questionable efficacy it has logistical and financial
implications that would make it quite unlikely to be explored in a
randomized fashion. In our view, in a STEMI setting, optimization
of all periprocedural parameters, including thrombus management by
pharmacologic and mechanical means, is the appropriate way to
go forward.
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Prophylactic Use of Hemodialysis
to Prevent Radiocontrast-Induced
Nephropathy
The Discussion Is Open Again!
Lee et al. (1) present very interesting results on the prophylactic
use of hemodialysis to prevent radiocontrast-induced nephropathy.
Unfortunately, the quality of their discussion falls behind the
quality of the data presented. The authors somehow fail to
mention that several randomized controlled studies have previously
failed to show an improvement of renal outcome by prophylactic
hemodialysis after radiocontrast media application and that a
recent meta-analysis of the controlled studies has revealed no
advantage of prophylactic hemodialysis with respect to outcome
(2). The failure to mention the previous controlled studies hin-
dered the authors to emphasize the differences between their study
and the ones previously done.
In contrast to previous studies including our own (2,3), the
authors were very careful to avoid intravascular volume depletion
during the prophylactic dialysis procedure. Not only was there no
ultrafiltration provided during dialysis, but saline was administered
at the beginning of the dialysis procedure to counteract expected
volume shifts out of the vascular space into the intracellular space
during dialysis. Although patients might have profited from the
careful volume control during the prophylactic dialysis session, it is
conceivable that the poor outcome of patients without dialysis
might have resulted from the lack of a comparable volume
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